alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of Bio-Imaging Technologies, Inc. (the Company) for the quarter ended March 31, 2005 as
filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Mark L. Weinstein, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:



(1) The Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and



(2) The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of Bio-Imaging Technologies, Inc.



|                    |  |                                                                                       
|------------------- |  | --------------------------------------------------------------------------------------
|                    |  | /s/ Mark L. Weinstein*                                                                
|Dated: May 16, 2005 |  | Mark L. Weinstein, President and Chief Executive
Officer (Principal Executive Officer)

---

|* | A signed original of this written statement required by Section 906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or its
staff upon request.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Page 23853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11789]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER09-1098-000]


DownEast Power Company, LLC; Supplemental Notice That Initial 
Market-Based Rate Filing Includes Request for Blanket Section 204 
Authorization

May 13, 2009.
    This is a supplemental notice in the above-referenced proceeding of 
DownEast Power Company, LLC's application for market-based rate 
authority, with an accompanying rate tariff, noting that such 
application includes a request for blanket authorization, under 18 CFR 
part 34, of future issuances of securities and assumptions of 
liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426, in accordance with Rules 211 and 214 of the 
Commission's Rules of Practice and Procedure (18 CFR 385.211 and 
385.214). Anyone filing a motion to intervene or protest must serve a 
copy of that document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability, is June 2, 2009.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
14 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First St., NE., Washington, DC, 20426.

Docket No. ER09-1098-000

    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for review in the Commission's 
Public Reference Room in Washington, DC. There is an eSubscription link 
on the Web site that enables subscribers to receive e-mail notification 
when a document is added to a subscribed dockets(s). For assistance 
with any FERC Online service, please e-mail <a href="/cdn-cgi/l/email-protection#3f797a6d7c70515356515a6c4a4f4f504d4b7f595a4d5c11585049"><span class="__cf_email__" data-cfemail="d3959681909cbdbfbabdb680a6a3a3bca1a793b5b6a1b0fdb4bca5">[email protected]</span></a>. 
or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-11789 Filed 5-20-09; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                         107,638
<SECURITIES>                                         0
<RECEIVABLES>                                1,072,873
<ALLOWANCES>                                         0
<INVENTORY>                                    290,000
<CURRENT-ASSETS>                             1,535,928
<PP&E>                                         252,581
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               5,603,510
<CURRENT-LIABILITIES>                        1,776,881
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       116,653
<OTHER-SE>                                   3,709,976
<TOTAL-LIABILITY-AND-EQUITY>                 3,826,629
<SALES>                                              0
<TOTAL-REVENUES>                             2,017,966
<CGS>                                        1,341,252
<TOTAL-COSTS>                                  646,570
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,551
<INCOME-PRETAX>                                 28,593
<INCOME-TAX>                                       400
<INCOME-CONTINUING>                             28,193
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    28,193
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
**EXHIBIT 32****CERTIFICATIONS**     On March 18, 2008, Questcor Pharmaceuticals, Inc. filed its Annual Report on Form 10-K forthe year ended December 31, 2007 (the “Form 10-K”) with the Securities and Exchange Commission.Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, thefollowing certifications are being made to accompany the Form 10-K:**Certification of Chief Executive Officer**     Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, theundersigned officer of Questcor Pharmaceuticals, Inc. (the “Company”) hereby certifies, to suchofficer’s knowledge, that:(i) the Annual Report on Form 10-K of the Company for the year ended December 31, 2007 (the“Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, ofthe Securities Exchange Act of 1934, as amended; and(ii) the information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.        Dated: March 18, 2008 /s/ Don M. Bailey   Don M. Bailey   Chief Executive Officer   The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.§ 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934,as amended, and is not to be incorporated by reference into any filing of the Company, whether madebefore or after the date hereof, regardless of any general incorporation language in such filing.**Certification of Chief Financial Officer**     Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, theundersigned officer of Questcor Pharmaceuticals, Inc. (the “Company”) hereby certifies, to suchofficer’s knowledge, that:(i) the Annual Report on Form 10-K of the Company for the year ended December 31, 2007 (the“Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, ofthe Securities Exchange Act of 1934, as amended; and(ii) the information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.        Dated: March 18, 2008 /s/ George Stuart   George Stuart   Chief Financial Officer   The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C.§ 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934,as amended, and is not to be incorporated by reference into any filing of the Company, whether madebefore or after the date hereof, regardless of any general incorporation language in such filing.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited Balance Sheet as of February 28,1997 and the unaudited Statement of
Operations for the six months then ended and is qualified in its entirety by
reference to such financial statments.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-31-1997
<PERIOD-START>                              DEC-1-1996
<PERIOD-END>                               FEB-28-1997
<CASH>                                           1,150
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     81,565
<CURRENT-ASSETS>                                92,990
<PP&E>                                          27,802
<DEPRECIATION>                                  22,289
<TOTAL-ASSETS>                               1,314,691
<CURRENT-LIABILITIES>                        1,558,654
<BONDS>                                        436,002
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,837,900
<OTHER-SE>                                  (4,097,615)
<TOTAL-LIABILITY-AND-EQUITY>                 1,314,691
<SALES>                                          5,470
<TOTAL-REVENUES>                                 5,470
<CGS>                                            2,461
<TOTAL-COSTS>                                  362,014
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              73,593
<INCOME-PRETAX>                               (430,137)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (430,137)
<EPS-PRIMARY>                                    (0.05)
<EPS-DILUTED>                                    (0.05)
        

</TABLE>
[Federal Register Volume 74, Number 104 (Tuesday, June 2, 2009)]
[Notices]
[Page 26456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12825]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6649]


Overseas Security Advisory Council (Osac) Meeting Notice; Closed 
Meeting

    The Department of State announces a meeting of the U.S. State 
Department--Overseas Security Advisory Council on June 16 at the U.S. 
Department of State, Arlington, Virginia and on June 17 at the U.S. 
Department of Homeland Security, Washington, DC. Pursuant to Section 
10(d) of the Federal Advisory Committee Act (5 U.S.C. Appendix), 5 
U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(7)(E), it has been determined 
that the meeting will be closed to the public. The meeting will focus 
on an examination of corporate security policies and procedures and 
will involve extensive discussion of trade secrets and proprietary 
commercial information that is privileged and confidential, and will 
discuss law enforcement investigative techniques and procedures. The 
agenda will include updated committee reports, a global threat 
overview, and other matters relating to private sector security 
policies and protective programs and the protection of U.S. business 
information overseas.
    For more information, contact Marsha Thurman, Overseas Security 
Advisory Council, Department of State, Washington, DC 20522-2008, 
phone: 571-345-2214.

    Dated: May 4, 2009.
Gregory B. Starr,
Director of the Diplomatic Security Service, Department of State.
[FR Doc. E9-12825 Filed 6-1-09; 8:45 am]
BILLING CODE 4710-43-P
EXHIBIT 23.02

                CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statements on Forms
S-3 (Registration No.'s 333-1314, 333-15959) and Forms S-8 (Registration No.'s
333-1136, 333-1138) of Sandston Corporation of our report dated March 11, 2005
on the financial statements of Sandston Corporation as of and for the year ended
December 31, 2004, appearing in the Annual Report on Form 10-KSB of Sandston
Corporation for the year ended December 31, 2004.

/s/ Plante & Moran, PLLC

Auburn Hills, Michigan
March 30, 2005
Exhibit 32.1**CERTIFICATION**1     Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the UnitedStates Code (18 U.S.C. § 1350), Jean-Loup Romet-Lemonne, M.D., the Chief Executive Officer of IDMPharma, Inc. (the “Company”), and Robert J. De Vaere, the Senior Vice President and Chief FinancialOfficer of the Company, each hereby certifies that, to the best of his knowledge:**1.**The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2007, to which thisCertification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with therequirements of Section 13(a) or Section 15(d) of the Exchange Act; and**2.**The information contained in the Periodic Report fairly presents, in all material respects, thefinancial condition of the Company at the end of the period covered by the Periodic Report andresults of operations of the Company for the period covered by the Periodic Report.Dated:May 15, 2007   /s/ Jean-Loup Romet-Lemonne /s/ Robert J. De VaereJean-Loup Romet-Lemonne, M.D. Robert J. De VaereChief Executive Officer Senior Vice President and Chief Financial Officer 1 This certification accompanies the Form10-Q to which it relates, is not deemedfiled with the Securities and ExchangeCommission and is not to be incorporated byreference into any filing of IDM Pharma,Inc. under the Securities Act of 1933, asamended, or the Securities Exchange Act of1934, as amended (whether made before orafter the date of the Form 10-Q),irrespective of any general incorporationlanguage contained in such filing.
50
**Exhibit 31.1****Sarbanes-Oxley Section 302 Certification**I, Stephen J. Hansbrough, certify that:1. I have reviewed this quarterly report on Form 10-Q of HearUSA, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis l report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluations; and  c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing the equivalent function): a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.Date: August 11, 2005   /s/Stephen J. Hansbrough     Stephen J. Hansbrough  Chief Executive Officer
#### UNITED STATES Of America, Plaintiff, and Kirell Francis TAYLOR, a/k/a Sadeeq Abdul Al Haqq; Dr. Sadeeq Abdul Al Haqq Kirell, Intervenor—Appellant, v. Zacarias Moussaoui, a/k/a Shaqil, a/k/a Abu Khalid al Sahrawi, Defendant.

No. 06-4407.

United States Court of Appeals, Fourth Circuit.

Submitted: June 15, 2006.

Decided: June 19, 2006.

Kirell Francis Taylor, Appellant Pro Se.

Before KING, SHEDD, and DUNCAN, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM:

Kirell Francis Taylor appeals a district court order denying his motion to intervene. We agree with the district court that the motion was frivolous. Accordingly, we deny Taylor’s motion to proceed in forma pauperis and dismiss his appeal as frivolous. We also deny his motion for an injunction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED*
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2687 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2687

To extend and modify the temporary suspension of duty on Aluminum tris 
                         (O-ethylphosphonate).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 2, 2009

   Mr. Burr introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend and modify the temporary suspension of duty on Aluminum tris 
                         (O-ethylphosphonate).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALUMINUM TRIS (O-ETHYLPHOSPHONATE).

    (a) In General.--Heading 9902.01.73 of the Harmonized Tariff 
Schedule of the United States (relating to Aluminum tris (O-
ethylphosphonate)) is amended--
            (1) by striking ``Free'' and inserting ``0.4%'';
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2011''; and
            (3) by striking the article description and inserting 
        ``Aluminum tris(O-ethylphosphonate) (CAS No. 39148-24-8) 
        (provided for in subheadings 2920.90.50 and 3808.92.50) whether 
        or not mixed with application adjuvants''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```